Session

S28 Emerging and future technologies for peripheral nerve regeneration

S28
Jun 29, 2022, 11:00โ€ฏAM
ICE Krakow

ICE Krakow

ul. Marii Konopnickiej 17 30-302 Krakรณw

Conveners

S28 Emerging and future technologies for peripheral nerve regeneration

  • Srinivas Madduri (University of Geneva)
  • Neha Tiwari (University of Bayreuth )

Presentation materials

There are no materials yet.

  1. Salgado, Antonio (ICVS, School of Medicine, University of Minho)
    6/29/22, 11:00โ€ฏAM
    invited lecture

    The low regeneration potential of the central nervous system (CNS) represents a challenge for the development of new therapeutic strategies. Mesenchymal stem cells (MSCs) have been proposed as a possible therapeutic tool for CNS disorders, namely due to the beneficial actions of their secretome. Indeed, the latter possesses a broad range of neuroregulatory factors that promote an increase in...

    Go to contribution page
  2. Madduri, Srinivas (University of Geneva)
    6/29/22, 11:20โ€ฏAM
    invited lecture
  3. Kordas, Antonis (Institute of Electronic Structure and Laser (IESL)-Foundation for Research and Technology Hellas (FORTH) )
    6/29/22, 11:40โ€ฏAM
    podium presentation

    Introduction
    Multi-Photon Polymerization (MPL) is a Direct Laser Writing (DLW) technique that combines ultrafast (femtosecond, fs) laser pulses and Computer Aided Designs (CADs) for the fabrication of high precision scaffolds that find application in fields such as tissue engineering [1, 2]. We used such scaffolds for mono- and co- cultures of murine N2a neuronal and SW10 glial cells in order...

    Go to contribution page
  4. Koci, Zuzana (Tissue Engineering Research Group, Dept. of Anatomy and Regenerative Medicine, Royal College of Surgeons in Ireland (RCSI), 2) Trinity Centre for Bioengineering, Trinity College Dublin (TCD), 3) Advanced Materials and Bioengineering Research)
    6/29/22, 11:50โ€ฏAM
    podium presentation

    Peripheral nerve injuries (PNI) affect millions of patients worldwide and cause motor and sensory dysfunction leading to reduced quality of life and increased healthcare costs. The primary treatment option for repairing large PNIs is to use patientโ€™s own nerve graft โ€“ an autograft, which is limited by availability and donor site morbidity. In this study, we aim to prepare an off-the-shelf...

    Go to contribution page
  5. Trueman, Ryan (University College London, Department of Pharmacology )
    6/29/22, 12:00โ€ฏPM
    podium presentation

    Introduction
    Peripheral nerve tissue engineering aims to create biomaterials that can replace and possibly even therapeutically surpass the current gold standard nerve autograft. Tissue-engineered constructs can be designed to deliver a combination of benefits to the regenerating nerve, such as supportive cells, alignment, extracellular matrix, soluble factors, and biomechanical integration....

    Go to contribution page
  6. Haertinger, Maximilian (Medical University of Vienna)
    6/29/22, 12:10โ€ฏPM
    podium presentation

    "Introduction. Extracellular vesicles (EVs) are involved in a plethora of physiological and pathophysiological contexts, and their potential regenerative applications have attracted special interest. Ease of autologous isolation, low immunogenicity and lack of reproductive potential are only some of the enticing characteristics that turn the spotlight increasingly towards EV-based therapy....

    Go to contribution page
  7. McMorrow, Liam Anthony (The University of Manchester )
    podium presentation

    Introduction,
    Clinically, reconstruction of a nerve gap can be performed with a nerve graft (carrying the risk of donor site morbidity) or with nerve guidance conduits (NGC), which are only applicable for small nerve defects. Both options are associated with poor outcomes for patients. Failure of current NGC to support regeneration across large defects (> 3cm) are thought due to a lack of...

    Go to contribution page
Building timetable...